| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $90.7M | +8.0% |
| Cost of Revenue | $1.1M | -10.2% |
| Gross Profit | $28.4M | +26.2% |
| R&D Expense | $3.9M | +33.5% |
| SG&A Expense | $15.3M | +214.6% |
| Operating Income | $7.5M | -40.3% |
| Pre-tax Income | $12.1M | -27.3% |
| Income Tax | $3.5M | +132.1% |
| Net Income | $4.9M | -64.9% |
| EPS (Basic) | $0.31 | -69.9% |
| EPS (Diluted) | $0.31 | -69.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.8M | +16.8% |
| Short-term Investments | $24.5M | +31.9% |
| Accounts Receivable | $17.3M | +9.2% |
| Inventory | $24.4M | +4.3% |
| Current Assets | $95.3M | +2.8% |
| Total Assets | $115.8M | +0.2% |
| Current Liabilities | $48.3M | -16.1% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.6M | +17.0% |
| Capital Expenditures | $526K | -73.2% |
| Investing Cash Flow | -$920K | +50.8% |
| Financing Cash Flow | -$15.6M | +49.5% |
| Free Cash Flow | $15.1M | +32.6% |
| $49.5M |
| -20.6% |
| Stockholders' Equity | $72.9M | +21.1% |